Cours Beleave Inc. Canadian Securities Exchange
Actions
BE
CA0775611084
Produits pharmaceutiques
CA 2018 | - | CA 2019 | 2,37 3,25 2,16 | Capitalisation | 30,37 M 41,55 M 27,58 M |
---|---|---|---|---|---|
Résultat net 2018 | -12 M -16,42 M -10,9 M | Résultat net 2019 | -33 M -45,15 M -29,97 M | VE / CA 2018 | - |
Trésorerie nette 2018 | 5,2 M 7,12 M 4,72 M | Dette nette 2019 | 10,32 M 14,11 M 9,37 M | VE / CA 2019 | 17 137 012 x |
PER 2018 |
-4,72
x | PER 2019 |
-0,76
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 98,39% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+43,17% | 6,29 Md | |
-14,69% | 4,55 Md | |
-8,17% | 3,23 Md | |
+6,95% | 3,27 Md | |
-1,76% | 2,56 Md | |
+50,20% | 2 Md | |
-7,85% | 1,68 Md | |
-0,40% | 1,64 Md | |
-9,91% | 1,59 Md |